NO20055097L - Krystallinske N-formyl-hydroksylaminforbindelser - Google Patents

Krystallinske N-formyl-hydroksylaminforbindelser

Info

Publication number
NO20055097L
NO20055097L NO20055097A NO20055097A NO20055097L NO 20055097 L NO20055097 L NO 20055097L NO 20055097 A NO20055097 A NO 20055097A NO 20055097 A NO20055097 A NO 20055097A NO 20055097 L NO20055097 L NO 20055097L
Authority
NO
Norway
Prior art keywords
compounds
crystalline
formyl
alkanes
hydroxylamine compounds
Prior art date
Application number
NO20055097A
Other languages
English (en)
Norwegian (no)
Other versions
NO20055097D0 (no
Inventor
Joel Slade
Martin Mueller
Hui Liu
Joginder Singh Bajwa
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33131903&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20055097(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of NO20055097D0 publication Critical patent/NO20055097D0/no
Publication of NO20055097L publication Critical patent/NO20055097L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/04Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
    • C07C259/06Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06Antimalarials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20055097A 2003-04-02 2005-11-01 Krystallinske N-formyl-hydroksylaminforbindelser NO20055097L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45972603P 2003-04-02 2003-04-02
PCT/EP2004/003478 WO2004087133A1 (en) 2003-04-02 2004-04-01 Crystalline n-formyl hydroxylamine compounds

Publications (2)

Publication Number Publication Date
NO20055097D0 NO20055097D0 (no) 2005-11-01
NO20055097L true NO20055097L (no) 2005-12-22

Family

ID=33131903

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20055097A NO20055097L (no) 2003-04-02 2005-11-01 Krystallinske N-formyl-hydroksylaminforbindelser

Country Status (25)

Country Link
US (1) US20070135353A1 (https=)
EP (1) EP1613305A1 (https=)
JP (1) JP2006522054A (https=)
KR (1) KR20060002915A (https=)
CN (1) CN1764450A (https=)
AR (1) AR043804A1 (https=)
AU (1) AU2004226815B2 (https=)
BR (1) BRPI0409009A (https=)
CA (1) CA2520682A1 (https=)
CL (1) CL2004000705A1 (https=)
CO (1) CO5630028A2 (https=)
EC (1) ECSP056043A (https=)
IS (1) IS8093A (https=)
MA (1) MA27763A1 (https=)
MX (1) MXPA05010610A (https=)
MY (1) MY136854A (https=)
NO (1) NO20055097L (https=)
NZ (1) NZ542432A (https=)
PE (1) PE20050392A1 (https=)
RU (1) RU2005133660A (https=)
SG (1) SG166681A1 (https=)
TN (1) TNSN05248A1 (https=)
TW (1) TW200427458A (https=)
WO (1) WO2004087133A1 (https=)
ZA (1) ZA200507179B (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1406893B1 (en) 2001-06-15 2007-04-18 Vicuron Pharmaceuticals, Inc. Pyrrolidine bicyclic compounds
ATE417826T1 (de) 2002-09-19 2009-01-15 Novartis Pharma Gmbh Verfahren zur herstellung von zwischenprodukten
MXPA05008842A (es) 2003-02-21 2005-10-05 Novartis Ag Proceso quimico.
GT200600196A (es) * 2005-05-23 2007-01-15 Compuestos n-formil de hidroxilamina
JP7001898B2 (ja) * 2016-05-11 2022-01-20 グアンドン・ヘボ・ファーマシューティカル・カンパニー・リミテッド スピロ3員環、スピロ5員環系ペプチドデホルミラーゼ阻害剤および抗菌と抗腫瘍におけるその使用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3282986A (en) * 1960-10-06 1966-11-01 Merck & Co Inc N-acylated hydroxamic acids and derivatives thereof
DK1052984T3 (da) * 1998-02-07 2004-09-20 Vernalis Oxford Ltd Antibakterielle midler
AR036053A1 (es) * 2001-06-15 2004-08-04 Versicor Inc Compuestos de n-formil-hidroxilamina, un proceso para su preparacion y composiciones farmaceuticas

Also Published As

Publication number Publication date
CA2520682A1 (en) 2004-10-14
US20070135353A1 (en) 2007-06-14
RU2005133660A (ru) 2006-06-10
AU2004226815B2 (en) 2007-07-19
NZ542432A (en) 2009-04-30
PE20050392A1 (es) 2005-06-19
TNSN05248A1 (en) 2007-06-11
MXPA05010610A (es) 2005-11-23
BRPI0409009A (pt) 2006-03-28
IS8093A (is) 2005-10-27
AU2004226815A1 (en) 2004-10-14
CO5630028A2 (es) 2006-04-28
SG166681A1 (en) 2010-12-29
CL2004000705A1 (es) 2005-01-14
WO2004087133A1 (en) 2004-10-14
MA27763A1 (fr) 2006-02-01
MY136854A (en) 2008-11-28
ZA200507179B (en) 2006-04-26
NO20055097D0 (no) 2005-11-01
KR20060002915A (ko) 2006-01-09
ECSP056043A (es) 2006-01-27
JP2006522054A (ja) 2006-09-28
TW200427458A (en) 2004-12-16
EP1613305A1 (en) 2006-01-11
AR043804A1 (es) 2005-08-10
CN1764450A (zh) 2006-04-26

Similar Documents

Publication Publication Date Title
NO20051600L (no) 1,4-disubstituerte piperidinderivater og anvendelse derav som 11-betaHSD1 inhibitorer
NO20062292L (no) Fremgangsmate for behandling av transplantasjonsavstoting
NO20044534L (no) Substituerte fenylacetamider og deres anvendelse som glukokinaseaktivatorer
NO20092033L (no) Nye forbindelser
NO20054852L (no) GFAT inhibitorer
NO20050065L (no) Kjemiske forbindelser
NO20070606L (no) Inhibitorer av IAP
NO20055680L (no) Heksahydropyridoisokinoliner som DPP-IV-inhibitorer
NO20060636L (no) Trisubstituerte aryl og heteroarylderivater som modulatorer av metabolisme og profylakse og behandling av lidelser relatert til dette
NO20055421L (no) Kinolinderivater som fosfodiestrase-inhibitorer
NO20055649L (no) Substituert dihydrokinazolin med antiviale egenskaper
NO20083006L (no) Anvendelse av benzofuserte heterocykliske sulfamidderivater for behandling av fedme
WO2006005609A3 (de) Substituierte oxindol-derivate und diese enthaltende arzneimittel
NO20070570L (no) Forbindelser.
NO20080710L (no) Dihydroksyantrakinoner og deres anvendelse
HRP20090159T1 (en) Use of glucosidase inhibitors for therapy of mucovisidosis
SE0203304D0 (sv) Novel Coumpounds
SE9803773D0 (sv) Compounds
NO20055097L (no) Krystallinske N-formyl-hydroksylaminforbindelser
NO20062629L (no) Oksazolderivater av tetrackliner
NO331012B1 (no) N-sulfonyl-4-metylenamino-3-hydroksy-2-pyridoner som antimikrobielle midler
ATE322908T1 (de) Ein kombinationsprodukt enthaltend melagatran und einen faktor xa inhibitor
NO20044550L (no) Heterotrisyklyl 6-alkaliden-penemer som beta-laktamaseinhibitorer
NO20012831L (no) Diazepinoindoler for behandling av kronisk obstruktiv lungesykdom
NO20060718L (no) Substituerte tiofoner og deres anvendelse

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application